BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deutsch TM, Stefanovic S, Feisst M, Fischer C, Riedel F, Fremd C, Domschke C, Pantel K, Hartkopf AD, Sutterlin M, Brucker SY, Schneeweiss A, Wallwiener M. Cut-Off Analysis of CTC Change under Systemic Therapy for Defining Early Therapy Response in Metastatic Breast Cancer. Cancers (Basel) 2020;12:E1055. [PMID: 32344685 DOI: 10.3390/cancers12041055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Deutsch TM, Riethdorf S, Fremd C, Feisst M, Nees J, Fischer C, Hartkopf AD, Pantel K, Trumpp A, Schütz F, Schneeweiss A, Wallwiener M. HER2-targeted therapy influences CTC status in metastatic breast cancer. Breast Cancer Res Treat 2020;182:127-36. [PMID: 32436146 DOI: 10.1007/s10549-020-05687-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
2 Galardi F, De Luca F, Biagioni C, Migliaccio I, Curigliano G, Minisini AM, Bonechi M, Moretti E, Risi E, McCartney A, Benelli M, Romagnoli D, Cappadona S, Gabellini S, Guarducci C, Conti V, Biganzoli L, Di Leo A, Malorni L. Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial. Breast Cancer Res 2021;23:38. [PMID: 33761970 DOI: 10.1186/s13058-021-01415-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Liu Y, Du Q, Sun D, Han R, Teng M, Chen S, You H, Dong Y. Clinical applications of circulating tumor DNA in monitoring breast cancer drug resistance. Future Oncol 2020;16:2863-78. [PMID: 32976028 DOI: 10.2217/fon-2019-0760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Rossi T, Gallerani G, Martinelli G, Maltoni R, Fabbri F. Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue. Biomedicines 2021;9:1242. [PMID: 34572427 DOI: 10.3390/biomedicines9091242] [Reference Citation Analysis]
5 Agnoletto C, Volinia S. Mitochondria dysfunction in circulating tumor cells. Front Oncol 2022;12:947479. [DOI: 10.3389/fonc.2022.947479] [Reference Citation Analysis]
6 Nees J, Schafferer S, Yuan B, Tang Q, Scheffler M, Hartkopf A, Golatta M, Schneeweiß A, Burwinkel B, Wallwiener M. How previous treatment changes the metabolomic profile in patients with metastatic breast cancer. Arch Gynecol Obstet 2022. [PMID: 35467121 DOI: 10.1007/s00404-022-06558-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Deutsch TM, Riethdorf S, Fremd C, Feisst M, Nees J, Fischer C, Hartkopf AD, Pantel K, Trumpp A, Schütz F, Schneeweiss A, Wallwiener M. HER2-targeted therapy influences CTC status in metastatic breast cancer. Breast Cancer Res Treat 2020;182:127-36. [PMID: 32436146 DOI: 10.1007/s10549-020-05687-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Keup C, Suryaprakash V, Storbeck M, Hoffmann O, Kimmig R, Kasimir-Bauer S. Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients. Cells 2021;10:212. [PMID: 33494385 DOI: 10.3390/cells10020212] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Park HA, Brown SR, Kim Y. Cellular Mechanisms of Circulating Tumor Cells During Breast Cancer Metastasis. Int J Mol Sci 2020;21:E5040. [PMID: 32708855 DOI: 10.3390/ijms21145040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ju S, Chen C, Zhang J, Xu L, Zhang X, Li Z, Chen Y, Zhou J, Ji F, Wang L. Detection of circulating tumor cells: opportunities and challenges. Biomark Res 2022;10:58. [PMID: 35962400 DOI: 10.1186/s40364-022-00403-2] [Reference Citation Analysis]
11 Hu X, Zang X, Lv Y. Detection of circulating tumor cells: Advances and critical concerns. Oncol Lett 2021;21:422. [PMID: 33850563 DOI: 10.3892/ol.2021.12683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]